Clinical Trials Directory

Trials / Unknown

UnknownNCT05339815

S-33 SMR Shoulder HP Reverse Glenosphere

Clinical and Radiographic Outcomes of Reverse Shoulder Arthroplasty Performed With 36-mm CoCrMo vs 40-mm Cross-linked UHMWPE Glenospheres.

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
Limacorporate S.p.a · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study Design: Single arm, retrospective and prospective, single center, post-market clinical study Purpose:To demonstrate the safety and effectiveness of the SMR Reverse HP Shoulder System device for primary, fracture or revision total shoulder replacement out to 24 months. The eligible study population is the entire population that underwent a reverse shoulder arthroplasty performed with 36-mm CoCrMo versus 40-mm cross-linked UHMWPE glenospheres between January 1, 2013 and January 1, 2020 at Wrightington Hospital (UK) in accordance with the indication for use of the product.

Conditions

Interventions

TypeNameDescription
DEVICESMR shoulder arthroplastyData collection of population that underwent a reverse shoulder arthroplasty performed with SMR 36-mm CoCrMo versus 40-mm cross-linked UHMWPE glenospheres

Timeline

Start date
2022-10-17
Primary completion
2023-02-01
Completion
2023-05-01
First posted
2022-04-21
Last updated
2022-10-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05339815. Inclusion in this directory is not an endorsement.